FDA Alerts Public on Accuracy Issues with Abbott’s Rapid COVID-19 Tests

What You Should Know:

FDA issues alert about accuracy concerns with Abbott’s ID Now COVID-19 rapid point-of-care tests that could return false negative results.

The FDA reports it is sharing early information available about potential inaccurate results in the spirit of transparency and is working with Abbott to analyze the information gathered to date.

On late Thursday, the U.S. Food and Drug Administration (FDA) issued an alert to the public about potential inaccurate COVID-19 testing results using Abbot’s ID NOW COVID-19 tests could return false-negative results. The FDA has received 15 adverse event

Leave a Reply